Rapid improvement in speech
in primary progressive aphasia following perispinal etanercept.
For the published results please see Perispinal etanercept
produces rapid improvement in primary progressive aphasia: identification
of a novel, rapidly reversible TNF-mediated pathophysiologic mechanisms.
Edward Tobinick MD. Medscape Journal of Medicine, Neurology
and Neurosurgery Clinical Cases 2008 June 10; 10(6):135. This
video was included as part of the peer-reviewed, published, scientific
article.The videos above are interviews discussing and documenting
the clinical response to initiation of anti-TNF treatment (perispinal
etanercept) at the INR. For the published results please see Tobinick
E, Gross H, Weinberger A, Cohen H., TNF-alpha Modulation
for Treatment of Alzheimer's Disease: A 6-Month Pilot Study
MedGenMed 2006; 8(2) :25; Tobinick E., Perispinal etanercept
for treatment of Alzheimer's disease, Current Alzheimer
Research 2007 Dec; 4(5):550-2; Tobinick E, Gross H., Rapid
improvement in verbal fluency and aphasia following perispinal
etanercept in Alzheimer's disease, BMC Neurology 2008;
8:27; and Tobinick E., Perispinal etanercept for neuroinflammatory
disorders, Drug Discovery Today 2009 Feb; 14(3-4):168-77.Institute for Neurological Research, a private medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California
90095
Video2